Plexus (NASDAQ:PLXS – Get Free Report) had its price target upped by investment analysts at Benchmark from $160.00 to $165.00 in a report released on Monday, MarketBeat.com reports. The firm presently has a “buy” rating on the technology company’s stock. Benchmark’s target price points to a potential upside of 13.53% from the stock’s current price.
A number of other analysts also recently commented on PLXS. Needham & Company LLC dropped their price objective on Plexus from $162.00 to $158.00 and set a “buy” rating for the company in a report on Thursday, July 24th. Stifel Nicolaus set a $140.00 price objective on Plexus in a report on Thursday, July 24th. Sidoti upgraded Plexus from a “neutral” rating to a “buy” rating and increased their price target for the company from $135.00 to $150.00 in a report on Friday, July 25th. Finally, Wall Street Zen downgraded Plexus from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 16th. Three analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $155.60.
Check Out Our Latest Analysis on PLXS
Plexus Trading Up 1.2%
Plexus (NASDAQ:PLXS – Get Free Report) last released its quarterly earnings data on Wednesday, July 23rd. The technology company reported $1.90 EPS for the quarter, topping analysts’ consensus estimates of $1.71 by $0.19. The business had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.02 billion. Plexus had a return on equity of 12.33% and a net margin of 4.04%.The business’s revenue for the quarter was up 6.0% on a year-over-year basis. During the same period in the prior year, the firm posted $1.45 EPS. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS. On average, equities research analysts expect that Plexus will post 5.9 EPS for the current year.
Insider Buying and Selling at Plexus
In other news, CEO Todd P. Kelsey sold 1,500 shares of the stock in a transaction dated Tuesday, September 2nd. The shares were sold at an average price of $134.54, for a total transaction of $201,810.00. Following the transaction, the chief executive officer owned 70,714 shares of the company’s stock, valued at approximately $9,513,861.56. This trade represents a 2.08% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Patrick John Jermain sold 2,500 shares of the stock in a transaction dated Wednesday, August 27th. The stock was sold at an average price of $137.71, for a total transaction of $344,275.00. Following the transaction, the chief financial officer directly owned 20,959 shares in the company, valued at $2,886,263.89. The trade was a 10.66% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 14,356 shares of company stock valued at $1,926,890. Corporate insiders own 1.76% of the company’s stock.
Hedge Funds Weigh In On Plexus
A number of large investors have recently bought and sold shares of the business. State Street Corp lifted its holdings in Plexus by 2.3% in the second quarter. State Street Corp now owns 1,059,501 shares of the technology company’s stock worth $143,361,000 after acquiring an additional 24,115 shares during the last quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. lifted its holdings in Plexus by 0.6% in the first quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 975,612 shares of the technology company’s stock worth $125,005,000 after acquiring an additional 6,257 shares during the last quarter. American Century Companies Inc. lifted its holdings in Plexus by 12.9% in the second quarter. American Century Companies Inc. now owns 765,773 shares of the technology company’s stock worth $103,617,000 after acquiring an additional 87,551 shares during the last quarter. Fuller & Thaler Asset Management Inc. lifted its holdings in Plexus by 120.4% in the first quarter. Fuller & Thaler Asset Management Inc. now owns 348,510 shares of the technology company’s stock worth $44,655,000 after acquiring an additional 190,360 shares during the last quarter. Finally, Qube Research & Technologies Ltd lifted its holdings in Plexus by 37.1% in the second quarter. Qube Research & Technologies Ltd now owns 242,726 shares of the technology company’s stock worth $32,843,000 after acquiring an additional 65,644 shares during the last quarter. Institutional investors own 94.45% of the company’s stock.
About Plexus
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Further Reading
- Five stocks we like better than Plexus
- Stock Splits, Do They Really Impact Investors?
- 3 Quantum Computing ETFs to Know—And Why 2 Don’t Hold D-Wave
- Asset Allocation Strategies in Volatile Markets
- Forget Tariffs, Landstar and West Fraser Can Still Rally
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Is Super Micro Next in Line for a Big AI Takeover?
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.